Merck MRK
NYSE MRK
$146.90 -3.47 (-2.31%)
At close: Nov 5, 2026 · 4:00 PM EST

Merck (MRK) Depreciation & Amortization (CF) (2009 - 2026)

Updated

Merck (MRK) reported Depreciation & Amortization (CF) of $599 million for Q2 2026, up 15.6% from $518 million a year earlier and up 3.1% from the prior quarter.

Analysis

Merck (MRK) Depreciation & Amortization (CF) (2009 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Merck's Depreciation & Amortization (CF) came in at $3.21 billion, up 53.0% year-over-year; for FY2025, it was $3.05 billion, up 44.7% from FY2024.

  • Depreciation & Amortization (CF) has increased for four consecutive years, with a five-year compound annual growth rate of 12.4% (FY2020 to FY2025).
  • By year, Depreciation & Amortization (CF) came in at $2.1 billion in FY2024 (+15.1%), $1.83 billion in FY2023 (+0.2%), $1.82 billion in FY2022 (+14.0%) and $1.6 billion in FY2021 (-5.9%).
  • Five-year quarterly Depreciation & Amortization (CF) spans a low of $399 million in Q3 2021 and a high of $1.49 billion in Q4 2025.
  • Year over year, Depreciation & Amortization (CF) has now increased in each of the last three quarters, with growth averaging 29.8% over the last eight quarters.
  • The high point for year-over-year Depreciation & Amortization (CF) in five years was Q4 2025 (growth of 186.0%); the low point was Q3 2021 (a decline of 53.2%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $581 million (Q1 2026), $1.49 billion (Q4 2025) and $532 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Eli Lilly 1,286.35 Bn 1,259.96 Bn 20.46 Bn 545.00 Mn
2 Johnson & Johnson 655.58 Bn 575.44 Bn 17.30 Bn 2.12 Bn
3 AbbVie 509.44 Bn 477.50 Bn 13.12 Bn 192.00 Mn
4 Merck 362.14 Bn 325.14 Bn 13.19 Bn 726.00 Mn
5 Novartis Ag 309.04 Bn 282.62 Bn - -
6 Astrazeneca 289.57 Bn 263.55 Bn 13.26 Bn 1.61 Bn
7 Amgen 248.97 Bn 200.62 Bn 7.58 Bn 1.12 Bn
8 Gilead Sciences 207.95 Bn 182.98 Bn 6.73 Bn 132.00 Mn
9 Pfizer 170.25 Bn 117.91 Bn 12.56 Bn 1.58 Bn
10 Vertex Pharmaceuticals 137.54 Bn 109.53 Bn 2.91 Bn 69.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 726.00 Mn
Jun 30, 2026 599.00 Mn
Mar 31, 2026 581.00 Mn
Dec 31, 2025 1.49 Bn
Sep 30, 2025 532.00 Mn
Jun 30, 2025 518.00 Mn
Mar 31, 2025 502.00 Mn
Dec 31, 2024 522.00 Mn
Sep 30, 2024 553.00 Mn
Jun 30, 2024 518.00 Mn
Mar 31, 2024 511.00 Mn
Dec 31, 2023 502.00 Mn
Sep 30, 2023 452.00 Mn
Jun 30, 2023 426.00 Mn
Mar 31, 2023 448.00 Mn
Dec 31, 2022 430.00 Mn
Sep 30, 2022 499.00 Mn
Jun 30, 2022 474.00 Mn
Mar 31, 2022 421.00 Mn
Dec 31, 2021 452.00 Mn
API Access

Merck Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=MRK&period=max&api_key=YOUR_API_KEY